PCV-20

20-valent pneumococcal conjugate vaccine · Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PCV-20, covering 2026-03-30 to 2026-03-30. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Safety PCV-20 of the Vaccine Administered During an Acute Febrile Illness in Adults [Phase 4]